复星医药获控股股东复星高科技质押2000万股及解除质押8575万股A股

Core Viewpoint - Fosun Pharma (600196)(02196) announced that its controlling shareholder, Shanghai Fosun High Technology (Group) Co., Ltd., has completed the pledge and release of part of its A-share holdings, indicating active management of its equity position [1] Summary by Category - Pledge and Release of Shares - The company reported that 20 million shares were pledged and 85.75 million shares were released from pledge [1]